Horizon Therapeutics Public Ltd Co

ARMISTICE CAPITAL, LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

88,000

Value ($000)

9,051

Weight

0.2%

2023 Q1 - 2023 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	9,051	0.2%	88,000	6/30/2023
2023 Q1	5/15/2023	22,701	0.5%	208,000	3/31/2023